Femtosecond laser-assisted cataract surgery
Related Experiment Video
Updated: Jun 6, 2026
An “All-laser” Endothelial Transplant
Published on: July 6, 2015
Lingmin He1, Katrina Sheehy, William Culbertson
1Department of Ophthalmology, Stanford University, Stanford, CA, USA.
Purpose Of Review:
In 2010, the US Food and Drug Administration (FDA) cleared femtosecond laser systems for cataract surgery. Available in 2011, this technology has the potential to significantly impact cataract surgery.
Recent Findings:
Femtosecond lasers offer surgeons the ability to make very precise cuts in a targeted area without damaging the surrounding tissues. This technology has already dramatically changed refractive surgery and is poised to do the same for cataract surgery. Three companies, OptiMedica, LenSx (acquired by Alcon in September 2010), and LensAR, in different stages of FDA clearance, are developing femtosecond laser systems for cataract surgery. These systems will create the initial corneal incisions, capsulotomy, and also fragment the lens.
Summary:
This article outlines the advantages of femtosecond laser cataract surgery and provides an initial comparison of the LensAR, LenSx/Alcon, and OptiMedica systems and early clinical results.
